Panagora Asset Management Has Cut Federated Investors (FII) Position By $917,616; Sunesis Pharmaceuticals, Inc. (SNSS) Had 1 Bullish Analysts

Among 4 analysts covering Sunesis Pharmaceuticals (NASDAQ:SNSS), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Sunesis Pharmaceuticals had 7 analyst reports since July 24, 2015 according to SRatingsIntel. TH Capital downgraded the stock to “Sell” rating in Friday, July 24 report. The firm has “Outperform” rating given on Friday, July 29 by Wells Fargo. Cowen & Co downgraded the shares of SNSS in report on Friday, July 24 to “Market Perform” rating. The stock has “Hold” rating by Cantor Fitzgerald on Thursday, July 27. Cantor Fitzgerald maintained it with “Hold” rating and $300 target in Tuesday, July 18 report. As per Friday, July 24, the company rating was downgraded by Cantor Fitzgerald. See Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) latest ratings: 02/11/2017 Broker: Cowen & Co Rating: Hold 27/07/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $3.0000 Maintain 18/07/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $3.0000 Maintain Panagora Asset Management Inc decreased Federated Investors Inc (FII) stake by 7.06% reported in 2017Q2 SEC filing. Panagora Asset Management Inc sold 32,772 shares as Federated Investors Inc (FII)’s stock declined 4.65%. The Panagora Asset Management Inc holds 431,745 shares with $12.20 million value, down from 464,517 last quarter. Federated Investors Inc now has $3.12B valuation. The stock rose 0.03% or $0.01 reaching $30.92. About 378,338 shares traded. Federated Investors Inc (NYSE:FII) has declined 14.01% since November 8, 2016 and is downtrending. It has underperformed by 30.71% the S&P500. About 71,101 shares traded. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has risen 8.33% since November 8, 2016 and is uptrending. It has underperformed by 8.37% the S&P500. Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $91.44 million. The Firm focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. It currently has negative earnings. The Firm offers QINPREZO , which is a product candidate for the treatment of acute myeloid leukemia (AML). Panagora Asset Management Inc increased Digital Realty Trust Inc (NYSE:DLR) stake by 71,335 shares to 369,620 valued at $41.75M in 2017Q2. It also upped Intercontinental Exchange In (NYSE:ICE) stake by 403,497 shares and now owns 486,504 shares. Fibrogen Inc was raised too. Investors sentiment increased to 1.19 in 2017 Q2. Its up 0.14, from 1.05 in 2017Q1. It improved, as 35 investors sold FII shares while 77 reduced holdings. 34 funds opened positions while 99 raised stakes. 77.77 million shares or 1.21% less from 78.72 million shares in 2017Q1 were reported. The Florida-based Raymond James & has invested 0% in Federated Investors Inc (NYSE:FII). Mutual Of America Capital Management Ltd Co reported 73,662 shares. Moreover, Stratos Wealth Prns Ltd has 0.22% invested in Federated Investors Inc (NYSE:FII). Swiss Comml Bank accumulated 151,517 shares. Lowe Brockenbrough holds 0.08% in Federated Investors Inc (NYSE:FII) or 18,000 shares. Moreover, Liberty Mutual Asset Management Incorporated has 0.04% invested in Federated Investors Inc (NYSE:FII). Los Angeles Capital Equity Research holds 231,850 shares or 0.04% of its portfolio. Dupont stated it has 0.02% in Federated Investors Inc (NYSE:FII). 3,574 were reported by Us Natl Bank De. Moreover, Principal Grp Inc Inc has 0.01% invested in Federated Investors Inc (NYSE:FII). Arizona State Retirement Sys holds 39,100 shares. Rodgers Brothers Inc has invested 1.06% in Federated Investors Inc (NYSE:FII). Cap City Trust Fl accumulated 64,689 shares or 0.71% of the stock. Amalgamated Bancorporation accumulated 18,610 shares or 0.02% of the stock. California Public Employees Retirement Systems owns 226,400 shares. Since June 16, 2017, it had 0 insider purchases, and 1 sale for $23,905 activity. Uhlman Paul A sold $23,905 worth of stock or 873 shares. Among 9 analysts covering Federated Investors (NYSE:FII), 0 have Buy rating, 2 Sell and 7 Hold. Therefore 0 are positive. Federated Investors had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods with “Sell” on Thursday, June 1. The firm earned “Underperform” rating on Monday, May 1 by Keefe Bruyette & Woods. The stock of Federated Investors Inc (NYSE:FII) has “Sell” rating given on Friday, September 1 by Keefe Bruyette & Woods. The stock of Federated Investors Inc (NYSE:FII) earned “Neutral” rating by Credit Suisse on Friday, November 18. The stock of Federated Investors Inc (NYSE:FII) earned “Buy” rating by Argus Research on Friday, January 29. Wood maintained the stock with “Market Perform” rating in Thursday, September 3 report. Citigroup maintained Federated Investors Inc (NYSE:FII) on Tuesday, October 31 with “Sell” rating. The stock of Federated Investors Inc (NYSE:FII) has “Hold” rating given on Tuesday, October 10 by Jefferies. Jefferies maintained the shares of FII in report on Wednesday, June 28 with “Hold” rating. JP Morgan upgraded the stock to “Neutral” rating in Thursday, May 25 report.